The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | M | Musculo-skeletal system | |
| 2 | M04 | Antigout preparations | |
| 3 | M04A | Antigout preparations | |
| 4 | M04AX | Other antigout preparations |
| Code | Title | |
|---|---|---|
| M04AX01 | Urate oxidase | |
| M04AX02 |
| Active Ingredient | Description | |
|---|---|---|
| Pegloticase |
Pegloticase is a uric acid specific enzyme which is a recombinant uricase and achieves its therapeutic effect by catalyzing the oxidation of uric acid to allantoin, thereby lowering serum uric acid. Allantoin is an inert and water soluble purine metabolite; it is readily eliminated, primarily by renal excretion. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| KRYSTEXXA Solution for infusion | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
